CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer
Table 2
Correlations between CD133 or ALDH1 expression and clinicopathological parameters in CNB of 102 primary breast cancers.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Correlations between CD133 or ALDH1 expression and clinicopathological parameters in CNB of 102 primary breast cancers.